Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis - Deveaux, V; Cadoudal, T; Ichigotani, Y; Teixeira-Clerc, F; Louvet, A; Manin, S; Nhieu, J T; Belot, M P; Zimmer, A; Even, P; Cani, P D; Knauf, C; Burcelin, R; Bertola, A; Le Marchand-Brustel, Y; Gual, P; Mallat, A; Lotersztajn, S (PLoS One, 2009)